Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ducloux

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Transplantation Proceedings|September 24, 1998
Mycophenolate mofetil in cyclosporine-associated nephrotoxicityD Ducloux, V Fournier, C Bresson-Vautrin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1998
Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipientsD Ducloux, C Ruedin, R Gibey, et al.
Clinical Nephrology|June 25, 2002
Hypertension in renal transplantation: donor and recipient risk factorsD Ducloux, G Motte, M Kribs, et al.
Transplantation|June 13, 1998
Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysisD Ducloux, J M Rebibou, S Semhoun-Ducloux, et al.
Transplantation Proceedings|March 15, 2000
Systemic hypertension and renal function in long-term liver transplant recipients on cyclosporineS Semhoun-Ducloux, D Ducloux, S Bresson-Hadni, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 1999
T-cell immune defect and B-cell activation in renal transplant recipients with monoclonal gammopathiesD Ducloux, P Carron, E Racadot, et al.
Transplantation|June 30, 1998
Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary reportD Ducloux, V Fournier, C Bresson-Vautrin, et al.
Kidney International|August 2, 2007
Hemodialysis reduces plasma apolipoprotein C-I concentration making VLDL a better substrate for lipoprotein lipaseG Dautin, Z Soltani, D Ducloux, et al.
Transplantation|January 28, 1999
Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipientsD Ducloux, E Pellet, V Fournier, et al.
Transplantation Proceedings|September 24, 1998
CD4 lymphocytopenia in long-term renal transplant recipientsD Ducloux, P L Carron, E Racadot, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Transplantation Proceedings|September 24, 1998
Mycophenolate mofetil in cyclosporine-associated nephrotoxicityD Ducloux, V Fournier, C Bresson-Vautrin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1998
Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipientsD Ducloux, C Ruedin, R Gibey, et al.
Clinical Nephrology|June 25, 2002
Hypertension in renal transplantation: donor and recipient risk factorsD Ducloux, G Motte, M Kribs, et al.
Transplantation|June 13, 1998
Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysisD Ducloux, J M Rebibou, S Semhoun-Ducloux, et al.
Transplantation Proceedings|March 15, 2000
Systemic hypertension and renal function in long-term liver transplant recipients on cyclosporineS Semhoun-Ducloux, D Ducloux, S Bresson-Hadni, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 1999
T-cell immune defect and B-cell activation in renal transplant recipients with monoclonal gammopathiesD Ducloux, P Carron, E Racadot, et al.
Transplantation|June 30, 1998
Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary reportD Ducloux, V Fournier, C Bresson-Vautrin, et al.
Kidney International|August 2, 2007
Hemodialysis reduces plasma apolipoprotein C-I concentration making VLDL a better substrate for lipoprotein lipaseG Dautin, Z Soltani, D Ducloux, et al.
Transplantation|January 28, 1999
Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipientsD Ducloux, E Pellet, V Fournier, et al.
Transplantation Proceedings|September 24, 1998
CD4 lymphocytopenia in long-term renal transplant recipientsD Ducloux, P L Carron, E Racadot, et al.
Pageof 8